Review



human m 6 a-modified lncrna epitranscriptomic microarray  (Arraystar inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Arraystar inc human m 6 a-modified lncrna epitranscriptomic microarray
    Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
    Human M 6 A Modified Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human m 6 a-modified lncrna epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human m 6 a-modified lncrna epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma"

    Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

    Journal: Clinical Epigenetics

    doi: 10.1186/s13148-023-01475-z

    Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
    Figure Legend Snippet: Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts

    Techniques Used: Modification, Microarray, Methylation, Expressing

    Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test
    Figure Legend Snippet: Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test

    Techniques Used: Modification, Expressing, Methylation, Biomarker Discovery

    The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators
    Figure Legend Snippet: The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators

    Techniques Used: Expressing

    Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001
    Figure Legend Snippet: Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001

    Techniques Used: Modification, Expressing



    Similar Products

    90
    Arraystar inc human m 6 a-modified lncrna epitranscriptomic microarray
    Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
    Human M 6 A Modified Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human m 6 a-modified lncrna epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human m 6 a-modified lncrna epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Arraystar inc human m 6 a-lncrna epitranscriptomic microarray
    Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
    Human M 6 A Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human m 6 a-lncrna epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human m 6 a-lncrna epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Arraystar inc human m 6 a-mrna&lncrna epitranscriptomic microarray
    Characteristics of the m 6 A-modified <t>lncRNA</t> <t>microarray</t> in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts
    Human M 6 A Mrna&Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human m 6 a-mrna&lncrna epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human m 6 a-mrna&lncrna epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Arraystar inc human m 6 a-mrna and lncrna epitranscriptomic microarray
    The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the <t>epitranscriptomic</t> rnicroarray sequence ( B ).
    Human M 6 A Mrna And Lncrna Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human m 6 a-mrna and lncrna epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human m 6 a-mrna and lncrna epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Arraystar inc human mrna and lncrna m 6 a epitranscriptomic microarray
    The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the <t>epitranscriptomic</t> rnicroarray sequence ( B ).
    Human Mrna And Lncrna M 6 A Epitranscriptomic Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human mrna and lncrna m 6 a epitranscriptomic microarray/product/Arraystar inc
    Average 90 stars, based on 1 article reviews
    human mrna and lncrna m 6 a epitranscriptomic microarray - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts

    Journal: Clinical Epigenetics

    Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

    doi: 10.1186/s13148-023-01475-z

    Figure Lengend Snippet: Characteristics of the m 6 A-modified lncRNA microarray in LUAD tumor tissues and adjacent normal tissues. A The source distribution of m 6 A-modified lncRNA transcripts. B The length distribution of m 6 A-modified lncRNA transcripts (≤ 3000 bp). C The chromosomal localization of m 6 A-modified lncRNA transcripts. D Volcano plot showed that in 2846 m 6 A-modified lncRNA transcripts, 143 were differentially modified (|log 2 FC|> 0.585, P < 0.05, unpaired t test), and 123 were hypermethylated and 20 were hypomethylated. E The methylation level heatmap of 143 differentially modified lncRNA transcripts. F Volcano plot showed that in 143 differentially modified lncRNA transcripts, 32 were upregulated and 48 were downregulated (|log 2 FC|> 1, P < 0.05, unpaired t test). G The expression level heatmap of 143 differentially modified lncRNA transcripts

    Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

    Techniques: Modification, Microarray, Methylation, Expressing

    Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test

    Journal: Clinical Epigenetics

    Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

    doi: 10.1186/s13148-023-01475-z

    Figure Lengend Snippet: Combined analyses of m 6 A modification and expression profiles of 143 differentially m 6 A-modified lncRNA transcripts in LUAD tissues. A The UpSet diagram was used to divide lncRNAs into six categories. B Spearman correlation analyses between the expression levels and methylation levels of 143 lncRNA transcripts in normal tissues (left), tumor tissues (middle), and all tissues (right). A point’s horizontal and vertical coordinates were the mean m 6 A level and mean expression level of a lncRNA transcript in six normal tissues (left), four tumor tissues (middle), and all ten tissues (right), respectively. C Validation of four lncRNAs’ expression levels in six pairs of clinical tissues; GAPDH served as the reference gene. * P < 0.05 and not significant (ns) P > 0.05. Paired t test. D Validation of four lncRNAs’ m 6 A levels in six pairs of clinical tissues by MeRIP-qPCR assays; Input was used as the reference. * P < 0.05, ** P < 0.01 and *** P < 0.001. Paired t test

    Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

    Techniques: Modification, Expressing, Methylation, Biomarker Discovery

    The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators

    Journal: Clinical Epigenetics

    Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

    doi: 10.1186/s13148-023-01475-z

    Figure Lengend Snippet: The screening of prognostic m 6 A-regulated lncRNAs. A The screening criteria of 215 m 6 A-regulated lncRNAs and its expression correlation with m 6 A regulators. B Forest plot of univariate Cox regression analysis of m 6 A-regulated lncRNAs ( P < 0.01). The hazard ratio (HR) value, its 95% confidence interval (CI), as well as the associated P value, were shown. HR > 1 indicated that the lncRNA was a risk factor and its high expression was unfavorable for prognosis, while the high expression of the protective lncRNA of HR < 1 was favorable for prognosis. C The expression correlation between 13 prognostic m 6 A-regulated lncRNAs and m 6 A regulators

    Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

    Techniques: Expressing

    Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001

    Journal: Clinical Epigenetics

    Article Title: Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m 6 A-modified long non-coding RNAs in lung adenocarcinoma

    doi: 10.1186/s13148-023-01475-z

    Figure Lengend Snippet: Construction of m 6 A-induced ceRNA Network. A The subcellular localization of 43 differentially m 6 A-modified lncRNAs according to RNALoate. B The construction process of the ceRNA network, which consisted of 11 correlative m 6 A regulators, seven differentially modified lncRNAs, 30 sponged miRNAs, and 110 targeted mRNAs. C The diagram of the ceRNA network. The lines connecting m 6 A regulators and lncRNAs represented RNA co-expression in TCGA-LUAD set (| r |> 0.3 and P < 0.001), and the red line represented the lncRNA-m 6 A regulator protein combination detected by CLIP-seq recorded in the POSTAR3 database. D The chart emphasized the dysregulated targeted mRNAs in LUAD, whose numbers of connecting nodes were greater than or equal to 3 in the ceRNA network. FC represented the expression fold change of T-median/N-median. WilcoxTest. *** P < 0.001

    Article Snippet: Importantly, the Arraystar Human M 6 A-modified LncRNA Epitranscriptomic Microarray was utilized to analyze the characteristics of m 6 A-modified lncRNAs and screen out lncRNAs with differential methylation level in LUAD.

    Techniques: Modification, Expressing

    The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the epitranscriptomic rnicroarray sequence ( B ).

    Journal: Scientific Reports

    Article Title: Human m 6 A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

    doi: 10.1038/s41598-021-99867-9

    Figure Lengend Snippet: The differentially expressed profile of m6A-mRNAs in immature red blood cells of Hb CS thalassemia (T) and healthy volunteers controls (N) (* P < 0.05.). Relative mRNA expression, as evidenced by qRT-PCR. The qRT-PCR data ( A ) was consistent with the epitranscriptomic rnicroarray sequence ( B ).

    Article Snippet: We conducted the Arraystar Human m 6 A-mRNA and lncRNA epitranscriptomic microarray analysis of 5 pairs of immature erythrocytes, particularly, 5 from HbH-CS thalassemia (T) and 5 from healthy volunteers (N).

    Techniques: Expressing, Quantitative RT-PCR, Sequencing

    The 20 differentially hypo-methylated m6A other RNAS including  lncRNA  and other small RNAs.

    Journal: Scientific Reports

    Article Title: Human m 6 A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

    doi: 10.1038/s41598-021-99867-9

    Figure Lengend Snippet: The 20 differentially hypo-methylated m6A other RNAS including lncRNA and other small RNAs.

    Article Snippet: We conducted the Arraystar Human m 6 A-mRNA and lncRNA epitranscriptomic microarray analysis of 5 pairs of immature erythrocytes, particularly, 5 from HbH-CS thalassemia (T) and 5 from healthy volunteers (N).

    Techniques: